Priority STD Testing Appears in 0.9% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending STD Tests. For more detail, you can also read STD Tests: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- Priority STD Testing appeared in 3 of 348 benchmark answers, or 0.86%, with no recommendations, top-three placements, or first-place mentions.
- The article treats November 2026 as a baseline, not a month-over-month trend, because earlier editions used a narrower question set.
- No conflicting claims were recorded in the captured answers, so the first step is to verify company facts and compare coverage with leading competitors.
- The strongest content opportunity centers on at-home herpes testing questions, where the company was mentioned but never recommended.
Answer Capsule
In November 2026, Priority STD Testing appeared in 3 of 348 AI answers included in the STD Tests benchmark (0.86%). It received 0 recommendations (0.00%), with 0 Top 3 placements and 0 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Priority STD Testing mentions, recommendations and placements compare with its STD Tests peers?
Priority STD Testing recorded 3 mentions (0.86%) and 0 recommendations (0.00%) across 348 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 3 neutral and 0 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Everlywell | 261 | 75.00% | 76 | 21.84% | 49 | 14.08% | 22 | 6.32% |
2 | myLAB Box | 226 | 64.94% | 71 | 20.40% | 57 | 16.38% | 17 | 4.89% |
3 | LetsGetChecked | 245 | 70.40% | 70 | 20.11% | 49 | 14.08% | 21 | 6.03% |
4 | Nurx | 120 | 34.48% | 22 | 6.32% | 7 | 2.01% | 2 | 0.57% |
5 | STDcheck.com | 53 | 15.23% | 12 | 3.45% | 2 | 0.57% | 1 | 0.29% |
6 | Labcorp OnDemand | 78 | 22.41% | 9 | 2.59% | 4 | 1.15% | 0 | 0.00% |
7 | QuestDirect | 22 | 6.32% | 3 | 0.86% | 1 | 0.29% | 1 | 0.29% |
8 | Health Testing Centers | 40 | 11.49% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
8 | Priority STD Testing | 3 | 0.86% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
8 | plushcare | 2 | 0.57% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
Priority STD Testing appears in a small share of the benchmark answers, and none of those appearances carried an endorsement. The mentions that were recorded read as neutral, so the company is being named without being put forward as a choice. That gap between being seen and being chosen is the practical starting point.
For a business reader, the useful reading is that awareness exists but preference does not. The agency would treat the neutral mentions as a foothold and set a realistic first target around earning affirmative recommendations, not around raw mention volume.
What changed since last month
Questions This Section Answers
- How did Priority STD Testing counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 3 / 348 (0.86%) |
Recommendations | 0 / 348 (0.00%) |
Top 3 recommendations | 0 / 348 (0.00%) |
#1 recommendations | 0 / 348 (0.00%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first broad baseline, so the monthly figures describe a starting position rather than movement from a prior month. Earlier editions used a narrower question set, which means their numbers are not a like-for-like comparison and should not be read as a trend.
The practical consequence is that future editions using the same screening scope become the real reference point. The agency would hold this month steady as the baseline and judge later results against it, while keeping the comparability caveat visible.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- Priority STD Testingno changeNov 20260.00%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Priority STD Testing?
AI answers contained 0 conflicting claims about Priority STD Testing: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
No conflicting claims about Priority STD Testing were recorded in the captured answers, so there is nothing in the fact-check queue to triage by severity. That is a clean starting point, but it is not proof that every statement about the company is accurate.
The agency would build a visibility comparison against the leading brands and a short register of claims worth verifying from primary sources. That pairing lets the client see where it stands and confirm its own facts before any content work begins.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Priority STD Testing should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
No disputed topics were supplied for this part of the analysis, so there is no claim to adjudicate and no page to rewrite on that basis. The agency would not invent a conflict to fill the gap.
Instead, the proposed work is to confirm the company's core facts from primary sources and prepare conditional page briefs only where a verified discrepancy appears. Entity, date and source checks come first, because different dates can explain an apparent conflict without any error existing.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Priority STD Testing?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://herpeschance.com/learn/best-at-home-herpes-testing-options-2026/ | 3 | 3 | 0 |
https://innerbody.com/best-at-home-herpes-test | 7 | 3 | 0 |
https://medicalnewstoday.com/articles/home-herpes-test | 4 | 3 | 0 |
https://health.yahoo.com/your-body/sexual-health/stis/herpes/article/at-home-herpes-test-kits-203224240.html | 3 | 3 | 0 |
https://cdc.gov/herpes/about/index.html | 1 | 1 | 0 |
https://hbmag.com/how-to-test-for-herpes-swab-blood-and-at-home-options/ | 1 | 1 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages cluster around at-home herpes testing, which is the topic where the company's mentions appear. Several of these are third-party comparison and health-information pages, and none carried a conflicting claim linked to Priority STD Testing.
The agency would review the current contents of the most relevant pages before making any request, since a citation does not show that a page influenced an answer. Where a genuine gap exists, evidence-backed outreach would follow; where it does not, the decision would be to leave the page alone.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Priority STD Testing website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://prioritystdtesting.com/blog/pink-sock-std/ | 1 | 0 | 0 |
The company's website was cited 1 times across 1 distinct page addresses; the table shows 1 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
Only one company page was cited, and it did not appear in answers that recommended the company. That tells us the site is being referenced occasionally but is not yet part of the recommending narrative.
The agency would prepare a page brief grounded in approved company facts and the questions buyers actually ask, then check existing coverage before proposing anything new. The brief is proposed work, not a claim that the current page is deficient.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Priority STD Testing?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
Can you test for herpes at home? | 2 | 1 | 0 |
Can you test for herpes at-home? | 3 | 1 | 0 |
Can you test yourself for herpes at home? | 3 | 1 | 0 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions all circle the same buyer concern: whether herpes testing can be done at home. The company was mentioned in answers to each phrasing but never recommended, which suggests the question set is relevant even though preference is missing.
The agency would turn these observations into content briefs that answer the question directly and clearly, after confirming what the site already covers. These are recorded answer observations, not search volume, so the briefs are a starting hypothesis rather than proven demand.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Priority STD Testing work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first phase sets the foundation: a baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and review status. Nothing is corrected until primary sources confirm it.
The middle phase produces approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately. The final phase adds buyer-question content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and no visibility gain is promised.
Methodology
Questions This Section Answers
- How are Priority STD Testing answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 348 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5470 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 348 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The answers were collected on dates that have not been verified, and the rates rest on the answers that met the benchmark's inclusion rules. A recommendation requires both an endorsement and positive wording, and top placements sit inside recommendations rather than adding to them.
Because one answer can mention several companies, company counts cannot be summed into distinct answers. Cited pages and disputed claims still need independent checking, and this edition is a broader baseline rather than a comparison with earlier, narrower editions.
Our first three priorities
The first priority is to confirm the company's own facts from primary sources and build the baseline scorecard, so later work rests on verified information rather than assumption. The second is to review the cited at-home herpes pages and decide, page by page, whether any evidence-backed request is warranted.
The third is to draft buyer-question content around at-home herpes testing, checking existing coverage first. Each step is proposed work with a clear owner, and none of it guarantees a change in how AI answers treat the company.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending STD Tests. For more detail, you can also read STD Tests: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


